UBE2L3 and gastric cancer: To clarify the potential clinical relevance of UBE2L3 in GC, we initially assessed the differential expression of UBE2L3 in GC tissues compared with adjacent normal tissues using immunohistochemical (IHC) staining on 125 specimens from 125 GC patients.